|
Q |
Colcr1 |
Colorectal carcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 4:1...29,494,328
|
|
Q |
Colcr2 |
Colorectal carcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:2,266,368...22,711,984
|
|
Q |
Colcr3 |
Colorectal carcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:2,249,477...22,066,430
|
|
Q |
Colcr4 |
Colorectal carcinoma resistance QTL4 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:20,338,777...62,613,667
|
|
Q |
Colcr5 |
Colorectal carcinoma resistance QTL 5 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:122,549,046...137,801,795
|
|
Q |
Colcr6 |
Colorectal carcinoma resistance QTL 6 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:73,690,518...99,794,247
|
|
Q |
Colcr7 |
Colorectal carcinoma resistance QTL 7 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr17:2,115,149...21,881,669
|
|
Q |
Colcr8 |
Colorectal carcinoma resistance QTL 8 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:22,066,242...52,293,055
|
|
Q |
Colcr9 |
Colorectal carcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr20:1,530,655...46,530,655
|
|
Q |
Colcs1 |
Colorectal carcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 5:121,846,814...166,846,814
|
|
|
Q |
Hcar1 |
Hepatocarcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr10:6,154,182...15,990,232
|
|
Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 8:40,713,066...82,925,667
|
|
Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 6:82,523,650...110,548,006
|
|
Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 3:29,463,235...118,376,539
|
|
Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 4:1...32,584,199
|
|
Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr18:51,464,733...83,218,561
|
|
Q |
Hcar2 |
Hepatocarcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 4:78,878,504...123,878,504
|
|
Q |
Hcar3 |
Hepatocarcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 8:54,237,644...99,103,503
|
|
Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 4:109,866,907...167,139,601
|
|
Q |
Hcas1 |
Hepatocarcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 7:91,412,594...129,807,172
|
|
Q |
Hcas2 |
Hepatocarcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 1:5,925,874...115,540,829
|
|
Q |
Hcas3 |
Hepatocarcinoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 1:144,267,353...222,987,745
|
|
Q |
Hcas4 |
Hepatocarcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr16:4,227,609...46,975,965
|
|
Q |
Hcas5 |
Hepatocarcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 1:176,426,412...257,976,495
|
|
Q |
Hcas6 |
Hepatocarcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr14:39,057,237...83,368,335
|
|
Q |
Hcas7 |
Hepatocarcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr15:2,266,368...46,921,453
|
|
Q |
Lnnr1 |
Liver neoplastic nodule remodeling QTL 1 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 7:34,293,282...79,293,282
|
|
Q |
Lnnr2 |
Liver neoplastic nodule remodeling QTL 2 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 1:233,948,574...260,522,016
|
|
Q |
Lnnr3 |
Liver neoplastic nodule remodeling QTL 3 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 2:1...41,244,106
|
|
Q |
Lnnr4 |
Liver neoplastic nodule remodeling QTL 4 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:1...42,356,786
|
|
Q |
Lnnr5 |
Liver neoplastic nodule remodeling QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:59,874,408...85,581,182
|
|
Q |
Lnnr6 |
Liver neoplastic nodule remodeling QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:74,862,117...85,581,182
|
|
|
Q |
Tcas10 |
Tongue tumor susceptibility QTL 10 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr10:31,297,439...76,297,439
|
|
Q |
Tcas11 |
Tongue tumor susceptibility QTL 11 |
|
IDA |
|
RGD |
PMID:16527513 |
RGD:1578522 |
NCBI chr 5:46,711,509...161,317,411
|
|
Q |
Tcas2 |
Tongue tumor susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:192,485,903...199,050,587
|
|
Q |
Tcas3 |
Tongue tumor susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 4:10,814,170...91,360,527
|
|
Q |
Tcas4 |
Tongue tumor susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr14:17,622,561...42,337,007
|
|
Q |
Tcas5 |
Tongue tumor susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr19:9,977,753...39,654,489
|
|
Q |
Tcas6 |
Tongue tumor susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:92,948,896...144,267,916
|
|
Q |
Tcas7 |
Tongue tumor susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15876484 |
RGD:1358147 |
NCBI chr19:24,817,978...39,654,489
|
|
Q |
Tcas8 |
Tongue tumor susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
|
|
Q |
Tcas9 |
Tongue tumor susceptibility QTL 9 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 6:1...37,618,905
|
|
|
Q |
Tcas1 |
Tongue tumor susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr19:2,316,121...47,316,121
|
|
Q |
Tcat1 |
Tongue tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr 1:99,267,916...144,267,916
|
|
|
Q |
Gcr1 |
Gastric cancer resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 4:120,260,281...147,278,687
|
|
Q |
Gcr2 |
Gastric cancer resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 3:8,658,162...27,494,778
|
|
Q |
Gcr3 |
Gastric cancer resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr16:17,696,791...82,635,055
|
|
Q |
Gcs1 |
Gastric cancer susceptibility QTL1 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr15:76,306,099...101,769,107
|
|
|
Q |
Tls1 |
T-lymphoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr 5:90,450,144...135,450,144
|
|
Q |
Tls2 |
T-lymphoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr 7:80,221,299...109,401,111
|
|
Q |
Tls3 |
T-lymphoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr10:51,774,612...95,600,334
|
|
|
Q |
Schws1 |
Schwannoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr10:40,035,094...102,359,817
|
|
Q |
Schws2 |
Schwannoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
|
|
Q |
Schws3 |
Schwannoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr 3:118,839,124...163,839,124
|
|
Q |
Schws4 |
Schwannoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr 6:83,190,345...106,747,639
|
|
Q |
Schws5 |
Schwannoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
|
|
Q |
Schws6 |
Schwannoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr15:53,806,152...98,806,152
|
|
Q |
Schws7 |
Schwannoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr10:4,765,527...19,816,042
|
|
Q |
Schws8 |
Schwannoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:94,968,928...139,968,928
|
|
Q |
Schws9 |
Schwannoma susceptibility QTL 9 |
|
IDA |
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:61,747,639...106,747,639
|
|
|
Q |
Mcs30 |
Mammary carcinoma susceptibility QTL 30 |
|
IDA |
|
RGD |
PMID:24023717 |
RGD:7327193 |
NCBI chr12:797,729...8,525,593
|
|
|
Q |
Hcar1 |
Hepatocarcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr10:6,154,182...15,990,232
|
|
Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 8:40,713,066...82,925,667
|
|
Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 6:82,523,650...110,548,006
|
|
Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 3:29,463,235...118,376,539
|
|
Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 4:1...32,584,199
|
|
Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr18:51,464,733...83,218,561
|
|
Q |
Hcar2 |
Hepatocarcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 4:78,878,504...123,878,504
|
|
Q |
Hcar3 |
Hepatocarcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 8:54,237,644...99,103,503
|
|
Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 4:109,866,907...167,139,601
|
|
Q |
Hcas1 |
Hepatocarcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 7:91,412,594...129,807,172
|
|
Q |
Hcas2 |
Hepatocarcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 1:5,925,874...115,540,829
|
|
Q |
Hcas3 |
Hepatocarcinoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 1:144,267,353...222,987,745
|
|
Q |
Hcas4 |
Hepatocarcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr16:4,227,609...46,975,965
|
|
Q |
Hcas5 |
Hepatocarcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 1:176,426,412...257,976,495
|
|
Q |
Hcas6 |
Hepatocarcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr14:39,057,237...83,368,335
|
|
Q |
Hcas7 |
Hepatocarcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr15:2,266,368...46,921,453
|
|
Q |
Hcas8 |
Hepatocarcinoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:17079458 |
RGD:1599590 |
NCBI chr16:1...22,477,621
|
|
Q |
Lnnr1 |
Liver neoplastic nodule remodeling QTL 1 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 7:34,293,282...79,293,282
|
|
Q |
Lnnr2 |
Liver neoplastic nodule remodeling QTL 2 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 1:233,948,574...260,522,016
|
|
Q |
Lnnr3 |
Liver neoplastic nodule remodeling QTL 3 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 2:1...41,244,106
|
|
Q |
Lnnr4 |
Liver neoplastic nodule remodeling QTL 4 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:1...42,356,786
|
|
Q |
Lnnr5 |
Liver neoplastic nodule remodeling QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:59,874,408...85,581,182
|
|
Q |
Lnnr6 |
Liver neoplastic nodule remodeling QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:74,862,117...85,581,182
|
|